CARL ZEISS MEDITEC AGCARL ZEISS MEDITEC AGCARL ZEISS MEDITEC AG

CARL ZEISS MEDITEC AG

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
Revenue estimate
Market capitalization
‪165.56 B‬MXN
‪5.35 B‬MXN
‪38.50 B‬MXN
‪36.55 M‬
Beta (1Y)
1.19

About CARL ZEISS MEDITEC AG

CEO
Markus Weber
Website
Headquarters
Jena
Employees (FY)
‪4.82 K‬
Founded
1995
ISIN
DE0005313704
FIGI
BBG01255HQ65
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. It operates through the Ophthalmic Strategic Business Unit (SBU) and Microsurgery business SBU segments. The Ophthalmic SBU segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. The Microsurgery SBU segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded in 2002 and is headquartered in Jena, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AFX/N is 3258.20 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange CARL ZEISS MEDITEC AG stocks are traded under the ticker AFX/N.
CARL ZEISS MEDITEC AG is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
AFX/N stock is 0% volatile and has beta coefficient of 1.19. Check out the list of the most volatile stocks — is CARL ZEISS MEDITEC AG there?
Yes, you can track CARL ZEISS MEDITEC AG financials in yearly and quarterly reports right on TradingView.
AFX/N net income for the last quarter is ‪3.27 B‬ MXN, while the quarter before that showed ‪2.21 B‬ MXN of net income which accounts for 47.86% change. Track more CARL ZEISS MEDITEC AG financial stats to get the full picture.
Today CARL ZEISS MEDITEC AG has the market capitalization of ‪165.56 B‬, it has increased by 2.13% over the last week.
Yes, AFX/N dividends are paid annually. The last dividend per share was 19.93 MXN. As of today, Dividend Yield (TTM)% is 1.10%. Tracking CARL ZEISS MEDITEC AG dividends might help you take more informed decisions.
CARL ZEISS MEDITEC AG dividend yield was 1.33% in 2023, and payout ratio reached 33.88%. The year before the numbers were 1.02% and 33.47% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AFX/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARL ZEISS MEDITEC AG stock right from TradingView charts — choose your broker and connect to your account.
AFX/N reached its all-time high on Sep 21, 2021 with the price of 4720.85 MXN, and its all-time low was 3258.20 MXN and was reached on Jan 26, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has ‪4.82 K‬ employees. See our rating of the largest employees — is CARL ZEISS MEDITEC AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARL ZEISS MEDITEC AG technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARL ZEISS MEDITEC AG stock shows the strong sell signal. See more of CARL ZEISS MEDITEC AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CARL ZEISS MEDITEC AG future price: according to them, AFX/N price has a max estimate of 2768.21 MXN and a min estimate of 1291.83 MXN. Read a more detailed CARL ZEISS MEDITEC AG forecast: see what analysts think of CARL ZEISS MEDITEC AG and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CARL ZEISS MEDITEC AG EBITDA is ‪7.86 B‬ MXN, and current EBITDA margin is 20.92%. See more stats in CARL ZEISS MEDITEC AG financial statements.